Hims & Hers Health shares (HIMS) surged 9% on Wednesday after Canaccord Genuity raised its price target on the telehealth company, citing improving sales trends, momentum in its weight-loss business, and growing optimism around its peptide opportunity.Canaccord analyst Maria Ripps maintained a Buy rating on the stock while increasing her…
Microsoft MSFT shares rose 4% on Wednesday after consumer health company Haleon announced a new five-year agreement to expand…
Robinhood HOOD shares surged 8% on Wednesday after the online brokerage unveiled a series of new products and international…
The Dow Jones Industrial Average touched a fresh intraday record on Wednesday before giving up most of its gains,…
Top Asian stocks in the memory industry retreated sharply today, July 2, as profit-taking gained steam. In Japan, Kioxia…
The Kospi Index slumped by over 7% as volatility in the South Korea’s equity market continued. It plunged to…
The Nikkei 225 Index has sold off recently as investors book profits following its strong rally to the all-time…
SoftBank Group stock rose on Thursday after a report said the Japanese investor had revived talks for a$10 billion…
Wall Street is heading into July with a more bullish tone after a volatile June, as strategists point to…